Compare Medtronic PLC (MDT) vs Visa Inc (V) Price & Performance

Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.

The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.

Visa (V) trades at $358.50, showing minimal daily movement (-0.02%) with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with consistent earnings beats, including Q1 2026 EPS of $3.31 versus $3.10 expected, and maintains exceptional profitability with 51.68% net income margin. Recent developments include the launch of Intelligent Commerce Connect to facilitate AI-powered commerce and expanded stablecoin partnerships.

Visa presents a compelling long-term investment case with 85% analyst buy ratings and $396.70 consensus price target suggesting 11% upside. The company's dominant payment network position, AI integration initiatives, and strong cash flow generation support continued growth, though investors should monitor competitive threats from fintech disruption and regulatory pressures that could impact future performance.